Literature DB >> 26070529

Gallbladder Cancer Incidence and Mortality, United States 1999-2011.

S Jane Henley1, Hannah K Weir2, Melissa A Jim2, Meg Watson2, Lisa C Richardson2.   

Abstract

BACKGROUND: Gallbladder cancer is a rare cancer with unusual distribution, and few population-based estimates for the United States have been published.
METHODS: Using population-based cancer incidence and mortality data, we examined U.S. gallbladder cancer incidence and death rates for 2007-2011 and trends for 1999-2011.
RESULTS: During 2007 to 2011, approximately 3,700 persons were diagnosed with primary gallbladder cancer (rate = 1.13 cases per 100,000) and 2,000 died from the disease (rate = 0.62 deaths per 100,000) each year in the United States. Two thirds of gallbladder cancer cases and deaths occurred among women. Gallbladder cancer incidence and death rates were three times higher among American Indian and Alaska Native persons than non-Hispanic white persons. By state, gallbladder cancer incidence and death rates ranged by about 2-fold. During 1999 to 2011, gallbladder cancer incidence rates decreased among women but remained level among men; death rates declined among women but stabilized among men after declining from 1999 to 2006. Gallbladder cancer incidence rates increased in some subgroups, notably among black persons, those aged <45 years, and for endocrine tumors.
CONCLUSIONS: Data from U.S. population-based cancer registries confirm that gallbladder cancer incidence and death rates are higher among women than men, highest among American Indian and Alaska Native persons, and differ by region. While overall incidence and death rates decreased during 1999 to 2011, incidence rates increased among some small subgroups. IMPACT: Surveillance of gallbladder cancer incidence and mortality, particularly to monitor increases in subgroups, may provide clues to etiology and stimulate further research. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2015        PMID: 26070529     DOI: 10.1158/1055-9965.EPI-15-0199

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  33 in total

Review 1.  Genome-Wide Association Studies of Cancer in Diverse Populations.

Authors:  Sungshim L Park; Iona Cheng; Christopher A Haiman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-06-21       Impact factor: 4.254

2.  Extended Lymphadenectomy Is Required for Incidental Gallbladder Cancer Independent of Cystic Duct Lymph Node Status.

Authors:  Eduardo A Vega; Eduardo Vinuela; Suguru Yamashita; Marcel Sanhueza; Gabriel Cavada; Cristian Diaz; Thomas A Aloia; Yun Shin Chun; Ching-Wei D Tzeng; Masayuki Okuno; Claire Goumard; Jean-Nicolas Vauthey; Jeffrey E Lee; Claudius Conrad
Journal:  J Gastrointest Surg       Date:  2017-07-27       Impact factor: 3.452

3.  Evaluation of abnormal gallbladder imaging findings: Surgical management and pathologic correlations in early-stage gallbladder cancer.

Authors:  Ellen J Spartz; Matthew Wheelwright; Tetyana Mettler; Khalid Amin; Nabeel Azeem; Mohamed Hassan; Jacob Ankeny; James V Harmon
Journal:  Clin Case Rep       Date:  2022-07-14

4.  Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013.

Authors:  Alison L Van Dyke; Meredith S Shiels; Gieira S Jones; Ruth M Pfeiffer; Jessica L Petrick; Jennifer L Beebe-Dimmer; Jill Koshiol
Journal:  Cancer       Date:  2019-01-15       Impact factor: 6.860

Review 5.  Genomic Profiling of Biliary Tract Cancers and Implications for Clinical Practice.

Authors:  Apurva Jain; Lawrence N Kwong; Milind Javle
Journal:  Curr Treat Options Oncol       Date:  2016-11

6.  Expression and mechanisms of long non-coding RNA genes MEG3 and ANRIL in gallbladder cancer.

Authors:  Bo Liu; Er-Dong Shen; Ming-Mei Liao; Yong-Bin Hu; Kai Wu; Pu Yang; Lin Zhou; Wei-Dong Chen
Journal:  Tumour Biol       Date:  2016-01-26

7.  Surgical management of biliary malignancy.

Authors:  T Peter Kingham; Victoria G Aveson; Alice C Wei; Jason A Castellanos; Peter J Allen; Daniel P Nussbaum; Yinin Hu; Michael I D'Angelica
Journal:  Curr Probl Surg       Date:  2020-06-30       Impact factor: 1.909

8.  IMbrave 151: a randomized phase II trial of atezolizumab combined with bevacizumab and chemotherapy in patients with advanced biliary tract cancer.

Authors:  Stephen P Hack; Wendy Verret; Sohail Mulla; Bo Liu; Yulei Wang; Teresa Macarulla; Zhenggang Ren; Anthony B El-Khoueiry; Andrew X Zhu
Journal:  Ther Adv Med Oncol       Date:  2021-07-31       Impact factor: 8.168

9.  Incidence and Mortality of Cancers of the Biliary Tract, Gallbladder, and Liver by Sex, Age, Race/Ethnicity, and Stage at Diagnosis: United States, 2013 to 2017.

Authors:  Taylor D Ellington; Behnoosh Momin; Reda J Wilson; S Jane Henley; Manxia Wu; A Blythe Ryerson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-07-08       Impact factor: 4.090

10.  Prognostic impact of lymphovascular invasion in pT1-T3 gallbladder adenocarcinoma.

Authors:  Dana A Dominguez; John G Aversa; Brendan L Hagerty; Laurence P Diggs; Mustafa Raoof; Jeremy L Davis; Jonathan M Hernandez; Andrew M Blakely
Journal:  J Surg Oncol       Date:  2020-08-11       Impact factor: 2.885

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.